Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2011

Open Access 01-12-2011 | Study protocol

Transfer of manualized Short Term Psychodynamic Psychotherapy (STPP) for social phobia into clinical practice: study protocol for a cluster-randomised controlled trial

Authors: Jörg Wiltink, Christian Ruckes, Antje Haselbacher, Marco Canterino, Falk Leichsenring, Peter Joraschky, Frank Leweke, Karin Pöhlmann, Manfred E Beutel

Published in: Trials | Issue 1/2011

Login to get access

Abstract

Background

Psychodynamic psychotherapy is frequently applied in the treatment of social phobia. Nevertheless, there has been a lack of studies on the transfer of manualized treatments to routine psychodynamic practice. Our study is the first one to examine the effects of additional training in a manualized Short Term Psychodynamic Psychotherapy (STPP) procedure on outcome in routine psychotherapy for social phobia. This study is an extension to a large multi-site RCT (N = 512) comparing the efficacy of STPP to Cognitive-Behavioral Therapy (CBT) of Social Phobia.

Methods/Design

The manualized treatment is designed for a time limited approach with 25 individual sessions of STPP over 6 months. Private practitioners will be randomized to training in manualized STPP vs. treatment as usual without a specific training (control condition). We plan to enrol a total of 105 patients (84 completers). Assessments will be conducted before treatment starts, after 8 and 15 weeks, after 25 treatment sessions, at the end of treatment, 6 months and 12 months after termination of treatment. The primary outcome measure is the Liebowitz Social Anxiety Scale. Remission from social phobia is defined scoring with 30 or less points on this scale.

Discussion

We will investigate how the treatment can be transferred from a controlled trial into the less structured setting of routine clinical care. This question represents Phase IV of psychotherapy research. It combines the benefits of randomized controlled and naturalistic research. The study is genuinely designed to promote faster and more widespread dissemination of effective interventions. It will answer the questions whether manualized STPP can be implemented into routine outpatient care, whether the new methods improve treatment courses and outcomes and whether treatment effects reached in routine psychotherapeutic treatments are comparable to those of the controlled, strictly manualized treatment of the main study.

Trial Registration

German Clinical Trials Register (DRKS) DRKS00000570
Appendix
Available only for authorised users
Literature
1.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision). 2000, Washington: APACrossRef
2.
Wittchen HU, Jacobi F: Die Versorgungssituation psychischer Störungen in Deutschland. Eine klinisch-epidemiologische Abschätzung anhand des Bundes-Gesundheitssurveys 1998. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2001, 44: 993-1000. 10.1007/s001030100269.CrossRef
3.
Fehm L, Beesdo K, Jacobi F, Fiedler A: Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population. Soc Psychiatry Psychiatr Epidemiol. 2008, 43: 257-265. 10.1007/s00127-007-0299-4.CrossRefPubMed
4.
Wittchen HU, Fehm L: Epidemiology and natural course of social fears and social phobia. Acta Psychiatr Scand. 2003, 108 (Suppl): 4-18.CrossRef
5.
Keller MB: The lifelong course of social anxiety disorder: a clinical perspective. Acta Psychiatr Scand. 2003, 108 (Suppl): 85-94.CrossRef
6.
Rüger U, Bell K: Historische Entwicklung und aktueller Stand der Richtlinien-Psychotherapie in Deutschland. Z Psychosom Med Psychother. 2004, 50: 127-152.PubMed
7.
Leichsenring F, Hoyer J, Beutel M, Herpertz S, Hiller W, Irle E, Joraschky P, König HH, de Liz TM, Nolting B, Pöhlmann K, Salzer S, Schauenburg H, Stangier U, Strauss B, Subic-Wrana C, Vormfelde S, Weniger G, Willutzki U, Wiltink J, Leibing E: The Social Phobia Psychotherapy Research Network (SOPHO-NET) - The first multi-center randomized controlled trial of psychotherapy for social phobia: rationale, methods and patient characteristics. Psychother Psychosom. 2009, 78: 35-41. 10.1159/000162299.CrossRefPubMed
8.
Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M: Strukturiertes Klinisches Interview für DSM-IV (SKID). 1996, Göttingen: Beltz-Test
9.
Stangier U, Heidenreich T: Die Liebowitz Soziale Angst - Skala (LSAS). Skalen für Psychiatrie. Edited by: Collegium Internationale Psychiatriae Scalarum, Internationale. 2004, Weinheim: Beltz
10.
Leichsenring F, Beutel ME, Leibing E: Psychoanalytisch orientierte Fokaltherapie der Sozialen Phobie. Psychotherapeut. 2008, 53: 185-197. 10.1007/s00278-007-0573-7.CrossRef
11.
Fydrich T: Soziale Phobie und Angstinventar (SPAI). Deutschsprachige Adaptation des 'Social Phobia and Anxiety Inventory' von Turner und Beidel. 2003, Göttingen: Hogrefe
12.
Guy W: ECDEU Assessment manual for psychopharmacology. 1976, Rockville, MD: US Department of Health and Human Services publication (ADM), 218-222.
13.
Bailer M, Worall H, Keller F: Beck-Depressions-Inventar (BDI). Testhandbuch. (2. überarbeitete Auflage). 1995, Bern: Hans Huber
14.
Deusinger IM: Die Frankfurter Selbstkonzeptskalen (FSKN). Handanweisung. 1986, Göttingen: Hogrefe
15.
Pöhlmann K, Thiel P, Joraschky P: Entwicklung und Validierung des Dresdner Körperbildfragebogens (DKB-35). Körperorientierte Diagnostik und Psychotherapie bei Essstörungen. Edited by: Joraschky P, Lausberg H, Pöhlmann K. 2008, Giessen: Psychosozial-Verlag, 57-72.
16.
Michal M, Sann U, Niebecker M, Lazanowsky C, Kernhof K, Aurich S, Overbeck G, Sierra M, Berrios GE: Die Erfassung des Depersonalisations-Derealisations-Syndroms mit der Deutschen Version der Cambridge Depersonalisation Scale (CDS). Psychother Psychosom Med Psychol. 2004, 54: 367-374. 10.1055/s-2004-828296.CrossRefPubMed
17.
Schulz U, Schwarzer R: Soziale Unterstützung bei der Krankheitsbewältigung. Die Berliner Social Support Skalen (BSSS). Diagnostica. 2003, 49: 73-82. 10.1026//0012-1924.49.2.73.CrossRef
18.
Graf von der Schulenburg JM, Claes C, Greiner W, Uber A: Die deutsche Version des EuroQol-Fragebogens. Z Gesundheitswiss. 1998, 6: 3-20.CrossRef
19.
Bassler M, Potratz B, Krauthauser H: Der "Helping Alliance Questionaire" (HAQ) von Luborsky. Möglichkeiten zur Evaluation des therapeutischen Prozesses von stationärer Psychotherapie. Psychotherapeut. 1995, 40: 23-32.
20.
Barber JP, Crits-Christoph P: Development of a therapist adherence/competence rating scale for supportive-expressive dynamic psychotherapy: a preliminary report. Psychotherapy Research. 1996, 6: 81-94. 10.1080/10503309612331331608.CrossRefPubMed
21.
Roick C, Kilian R, Matschinger H, Bernert S, Mory C, Angermeyer MC: German adaptation of the client sociodemographic and service receipt inventory - an instrument for the cost of mental health care. Psychiatr Prax. 2001, 28 (suppl 2): S84-S90.CrossRefPubMed
22.
Abbass AA, Hancock JT, Henderson J, Kisely S: Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2006, 18 (4): CD004687-
23.
Leichsenring F, Rabung S, Leibing E: The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry. 2004, 61: 1208-1216. 10.1001/archpsyc.61.12.1208.CrossRefPubMed
24.
Campbell MJ, Mollison J, Grimshaw JM: Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Stat Med. 2001, 20: 391-399. 10.1002/1097-0258(20010215)20:3<391::AID-SIM800>3.0.CO;2-Z.CrossRefPubMed
25.
Davidson JR, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM: Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry. 2004, 61: 1005-1013. 10.1001/archpsyc.61.10.1005.CrossRefPubMed
26.
Schroeder JR, Schmittner JP, Epstein DH, Preston KL: Adverse events among patients in a behavioral treatment for heroin and cocaine dependence: effects of age, race, and gender. Drug Alcohol Depend. 2005, 80: 45-51. 10.1016/j.drugalcdep.2005.03.007.CrossRefPubMed
Metadata
Title
Transfer of manualized Short Term Psychodynamic Psychotherapy (STPP) for social phobia into clinical practice: study protocol for a cluster-randomised controlled trial
Authors
Jörg Wiltink
Christian Ruckes
Antje Haselbacher
Marco Canterino
Falk Leichsenring
Peter Joraschky
Frank Leweke
Karin Pöhlmann
Manfred E Beutel
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Trials / Issue 1/2011
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-12-142

Other articles of this Issue 1/2011

Trials 1/2011 Go to the issue

Study protocol

Hand-suture versus stapling for closure of loop ileostomy: HASTA-Trial: a study rationale and design for a randomized controlled trial

Methodology

Use of deferred consent for severely ill children in a multi-centre phase III trial

Study protocol

Randomised social-skills training and parental training plus standard treatment versus standard treatment of children with attention deficit hyperactivity disorder - The SOSTRA trial protocol

Study protocol

Prevention of: self harm in British South Asian women: study protocol of an exploratory RCT of culturally adapted manual assisted Problem Solving Training (C- MAP)

Study protocol

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Study protocol

Alzheimer's disease - input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial